Question 1

Does Walleye Capital own TVTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Walleye Capital holds 38,762 shares of TVTX (Travere Therapeutics), worth $2.2M.

Question 2

How many shares of TVTX does Walleye Capital own?

Accepted Answer

As of its Q2 2026 13F, Walleye Capital holds 38,762 shares of TVTX (Travere Therapeutics).

Question 3

What is Walleye Capital's TVTX position worth?

Accepted Answer

As of its Q2 2026 13F, Walleye Capital's TVTX position is worth $2.2M.

Question 4

Is Walleye Capital buying or selling TVTX?

Accepted Answer

In Q2 2026, Walleye Capital increased its TVTX position from 402 to 38,762 shares.

Question 5

When did Walleye Capital first buy TVTX?

Accepted Answer

Walleye Capital first reported TVTX in its Q1 2021 13F and has listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	38,762	+9542.3%	$2.2M	0.0%	$56.81	42
2026-Q1	Decreased	402	-92.6%	$11,943	0.0%	$29.71	0
2025-Q4	Decreased	5,454	-91.6%	$208,397	0.0%	$38.21	0
2025-Q3	Decreased	65,141	-66.0%	$1.6M	0.0%	$23.90	0
2025-Q2	Decreased	191,867	-28.7%	$2.8M	0.0%	$14.80	0
2025-Q1	Decreased	269,138	-37.0%	$4.8M	0.0%	$17.92	0
2024-Q4	Decreased	427,230	-12.5%	$7.4M	0.0%	$17.42	0
2024-Q3	Increased	488,453	+83.3%	$6.8M	0.0%	$13.99	42